BSW Wealth Partners’s Array Biopharma Inc ARRY Stock Holding History

BSW Wealth Partners’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-20,000	Closed	-$246K	–	98
2017 Q3	$246K	Buy	+20,000	New	+$186K	0.11%	71
2016 Q4	–	Sell	-68	Closed	-$10K	–	79
2016 Q3	$10K	Sell	68 -9,932	-99%	-$38.4K	0.35%	35
2016 Q2	$36K	Hold	10,000	–	–	0.02%	68
2016 Q1	$30K	Hold	10,000	–	–	0.02%	63
2015 Q4	$42K	Hold	10,000	–	–	0.02%	63
2015 Q3	$46K	Hold	10,000	–	–	0.03%	60
2015 Q2	$74K	Hold	10,000	–	–	0.05%	59
2015 Q1	$74K	Sell	10,000 -10,000	-50%	-$71.2K	0.05%	52
2014 Q4	$95K	Hold	20,000	–	–	0.08%	54
2014 Q3	$71K	Sell	20,000 -540	-3%	-$2.13K	0.06%	53
2014 Q2	$94K	Buy	20,540 +540	+3%	+$2.23K	0.07%	49
2014 Q1	$94K	Hold	20,000	–	–	0.08%	49
2013 Q4	$100K	Hold	20,000	–	–	0.08%	49
2013 Q3	$124K	Hold	20,000	–	–	0.11%	45
2013 Q2	$91K	Buy	+20,000	New	+$108K	0.08%	46

Other funds holding ARRY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BSW Wealth Partners's ARRY Position: Q4 2017 in Review

BSW Wealth Partners sold out of Array Biopharma Inc (ARRY) in Q4 2017, closing a stake of 20,000 shares — an estimated $246K sold.

BSW Wealth Partners first reported a position in ARRY in Q2 2013 and held it in 15 quarters. The position peaked at $246K in Q3 2017. 191 funds tracked by Wall St. Rank hold ARRY as of Q4 2017.

BSW Wealth Partners reported no remaining Array Biopharma Inc position as of Q4 2017 after selling out during the quarter.
BSW Wealth Partners sold 20,000 Array Biopharma Inc shares in Q4 2017, an estimated $246K.
BSW Wealth Partners first reported a position in Array Biopharma Inc in Q2 2013 and held it in 15 quarters.
BSW Wealth Partners's Array Biopharma Inc position peaked at $246K in Q3 2017.
191 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2017.

Based on BSW Wealth Partners's 13F filing for Q4 2017, filed 8 Feb 2018.